Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Andrew Spaventa is Director at Aspen Neuroscience. OQRO lists 4 transactions filed with the SEC under this name, the latest on Nov 3, 2026, each linked to the official Form 4.
Director
Disclosures on record
4
Companies involved
1
Aspen NeuroscienceASPE
4 disclosures · Nov 2026
Nov 2, 202670Kdisclosed Nov 3
DetailsOfficial recordNov 2, 2026180Kdisclosed Nov 3
DetailsOfficial recordNov 2, 202670Kdisclosed Nov 3
DetailsOfficial recordNov 2, 2026180Kdisclosed Nov 3
DetailsOfficial recordOn the latest SEC Form 4, dated Nov 2, 2026, Andrew Spaventa reported holding 250,415 shares of Aspen Neuroscience (ASPE), held indirectly. At the last close of $13 on Nov 13, 2026, that is about $3.15M. This is the stake disclosed in filings, not a net worth.
As of the latest filing on , Andrew Spaventa reported holding 250,415 shares of Aspen Neuroscience (ASPE), worth about $3.15M at the last close of $13 (Nov 13, 2026), held through a see footnote 3, a see footnote 2.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aspen Neuroscience ASPE | 250,415 | 180K see footnote 3 · 70K see footnote 2 | $13 | $3.15M | Nov 2, 2026 |
Is this Andrew Spaventa’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.